Biblioteca Humberto Rosselli Quijano
[artículo]
| Título : |
Effect of aripiprazole augmentation of serotonin reuptake inhibitors or clomipramine in treatment resistant obsessive compulsive disorder : A double blind, placebo controlled study |
| Tipo de documento: |
texto impreso |
| Autores: |
Maria Rosaria A. Muscatello, Autor ; Antonio Bruno, Autor ; Gianluca Pandolfo, Autor |
| Fecha de publicación: |
2022 |
| Artículo en la página: |
pp. 174-179 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Aripiprazol, Inhibidores de la recaptación de serotonina, Clomipramina, Trastorno obsesivo-compulsivo |
| Resumen: |
Based on the evidence that aripiprazole added to serotonin reuptake inhibitors (SRIs) or clomipramine in treatment-resistant obsessive-compulsive disorder (OCD) has reported promising results, the present 16-week, double-blind, randomized, placebo-controlled trial had the aim to explore the efficacy of aripiprazole add-on pharmacotherapy on clinical symptoms and cognitive functioning in a sample of treatment-resistant OCD patients receiving SRIs. |
| Link: |
./index.php?lvl=notice_display&id=29386 |
in Journal of Clinical Psychopharmacology > Año 2011 - Vol. 31 - No. 2 (Abril) . - pp. 174-179
|
